Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 619 is a human DNA-binding transcription factor belonging to the zinc finger protein family. It is predicted to regulate gene expression by binding to specific DNA sequences and influencing transcription, primarily through RNA polymerase II. The protein contains zinc finger domains which stabilize its structure and mediate sequence-specific interactions with DNA. ZNF619 is encoded by a protein-coding gene expressed predominantly in the nucleus and is involved in transcriptional regulation. It has been linked (primarily by genetic association) to certain rare developmental disorders but is not established as a major therapeutic target or biomarker for human disease. Its expression has been studied in various tissues, including cancer, but its functional role in pathology remains unclear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 619 (ZNF619).